News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,036 signal articles · 531 in last 24h · 103,484 total before filter · latest 14m ago

531last 24h

2514last 7d

484● bullish (7d)

257● bearish (7d)

197publishers

All Macro243 Earnings1482 M&A141 Regulatory16 Product4 Analyst29

✕ clear all filtersticker: JPMsentiment: bullishSentiment:bullish neutral bearish show all (incl. clickbait)

Investing.com55d agobullish

Illumina upgraded to overweight at JPMorgan on clinical demand outlook

Investing.com -- Illumina received a bullish rating upgrade from JPMorgan, which raised its recommendation to Overweight from Neutral and lifted its December 2026 price target to $185 from $125, citing growing confidence in the DNA sequencing company's ability to sustain strong growth despite increasing competition.

JPM